C-Graft

The Clinician’s Preference Announces FDA 510K Clearance For Innovative, New Bone Grafting Material C-Graft™
Posted: December 15, 2003
The Clinician’s Preference today announced that C-Graft™ has been granted 510K clearance by the FDA and is now available for sale in the United States.

Derived from calcified, marine algae, C-Graft™ is a natural, non-animal choice for bone grafting and features the key building blocks for successful bone regeneration…Porosity, Absorption and Resorption.

Dean Fallander, President, The Clinician’s Preference, commented, “We are obviously extremely pleased to receive FDA clearance for C-Graft™ and are looking forward to enabling clinicians throughout the US to take advantage of what we believe to be an extremely innovative and effective product.”

The Clinician’s Preference maintains its corporate headquarters in Golden, Colorado and is committed to providing clinicians the very best and most cost-efficient bone grafting materials. Established in 2003, The Clinician’s Preference currently carries C-Graft™, OrthoBlast™II…an allograft featuring cancellous bone and demineralized bone matrix (DBM) in the same carrier, and REGUARDE™…a Type I collagen, resorbable membrane.

Views: 19
Sponsors
Townie Perks
Townie® Poll
Who or what do you turn to for most financial advice regarding your practice?
  
The Dentaltown Team, Farran Media Support
Phone: +1-480-445-9710
Email: support@farranmedia.com
©2025 Dentaltown, a division of Farran Media • All Rights Reserved
9633 S. 48th Street Suite 200 • Phoenix, AZ 85044 • Phone:+1-480-598-0001 • Fax:+1-480-598-3450